SPRB

Spruce Biosciences

30 hedge funds and large institutions have $20M invested in Spruce Biosciences in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 9 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
30
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$55.3K
2 +$19.6K
3 +$4.61K
4
TRCT
Tower Research Capital (TRC)
New York
+$3.96K
5
Millennium Management
Millennium Management
New York
+$2.73K

Top Sellers

1 -$32K
2 -$29K
3 -$27K
4
Morgan Stanley
Morgan Stanley
New York
-$21.8K
5
SG
StoneX Group
New York
-$13.8K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$4.95M
2
$2.36M
3
$2.33M
4
$1.97M
5
$1.92M
6
$1.78M
7
$1.32M
8
$1.1M
9
$866K
10
$243K
11
$165K
12
$162K
13
$152K
14
$137K
15
$102K
16
$101K
17
$75K
18
$66K
19
$66K
20
$55.3K
21
$15.4K
22
$12K
23
$8K
24
$6.21K
25
$3.66K